Serial Number:
86701322
Mark:
Status:
Abandoned-No Statement of Use filed
Status Date:
08-19-2019
Filing Date:
Registration Number:
N/A
Registration Date:
N/A
Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, all for in-vivo laboratory use in gene therapy Pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, and fungal and viral diseases and disorders; pharmaceutical preparations for the treatment of cancer, pain, diabetes, damaged skin, damaged tissue and addiction; Gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceutical preparations for the treatment of genetic diseases and disorders
Mark Description:
The mark consists of DNA-like strand within a hexagon.
Class:
Pharmaceutical and veterinary preparations
Type of Mark:
Trademark
Published for Opposition Date:
05-24-2016
Owner:
Mark Drawing Status:
Design Only
Abandon Date:
08-19-2019
Business Name:
GOODWIN PROCTER LLP
Correspondent Name:
